Antinuclear factor in rapid and slow acetylator patients treated with isoniazid

A phase 1 study of OSI-930 in combination with erlotinib in patients with advanced solid tumours.

European journal of cancer (Oxford, England : 1990)·2012

Proneness to psychological distress and risk of Alzheimer disease in a biracial community.

Neurology·2005

Social resources and cognitive decline in a population of older African Americans and whites.

Neurology·2004

Influence of behavioral symptoms on rates of institutionalization for persons with Alzheimer's disease.

Psychological medicine·2004

Education and the course of cognitive decline in Alzheimer disease.

Neurology·2004

Diabetes mellitus and progression of rigidity and gait disturbance in older persons.

Neurology·2004

Founder variant in OTOG causing non-syndromic sensorineural hearing loss in Irish traveller population.

Journal of medical genetics·2026

Risk of breast cancer after ovarian cancer in germline BRCA1/2 heterozygotes.

Journal of medical genetics·2026

Rapid minigene workflow for functional reclassification of splicing variants in hereditary cancer diagnostics.

Journal of medical genetics·2026

Childhood-onset neurodegeneration and brain atrophy: defining UBTF-related developmental regression and progressive ataxia.

Journal of medical genetics·2026

BHLHE22 monoallelic and biallelic variants cause a neurodevelopmental disorder with agenesis of the corpus callosum, intellectual disability, abnormal muscle tone and movement abnormalities.

Journal of medical genetics·2026

Evolving roles within the genomic medicine workforce: a revised framework for UK practice-position on behalf of the Association of Genetic Nurses and Counsellors and the Clinical Genetics Society.

Journal of medical genetics·2026

B-cell depletion therapy in systemic lupus erythematosus: emerging strategies and challenges.

Expert opinion on biological therapy·2026

68Ga-FAPI PET/CT for assessing fibroblast activation and disease activity in primary Sjögren's disease: a prospective case-control study.

Rheumatology (Oxford, England)·2026

Rheumatoid arthritis flares and de novo inflammatory arthritis after immune checkpoint inhibitor therapy: a single-center exploratory study of clinical phenotypes.

Immunological medicine·2026

Related Experiment Videos

Antinuclear factor in rapid and slow acetylator patients treated with isoniazid

Related Concept Videos

A phase 1 study of OSI-930 in combination with erlotinib in patients with advanced solid tumours.

Proneness to psychological distress and risk of Alzheimer disease in a biracial community.

Social resources and cognitive decline in a population of older African Americans and whites.

Influence of behavioral symptoms on rates of institutionalization for persons with Alzheimer's disease.

Education and the course of cognitive decline in Alzheimer disease.

Diabetes mellitus and progression of rigidity and gait disturbance in older persons.

Founder variant in OTOG causing non-syndromic sensorineural hearing loss in Irish traveller population.

Risk of breast cancer after ovarian cancer in germline BRCA1/2 heterozygotes.

Rapid minigene workflow for functional reclassification of splicing variants in hereditary cancer diagnostics.

Childhood-onset neurodegeneration and brain atrophy: defining UBTF-related developmental regression and progressive ataxia.

BHLHE22 monoallelic and biallelic variants cause a neurodevelopmental disorder with agenesis of the corpus callosum, intellectual disability, abnormal muscle tone and movement abnormalities.

Evolving roles within the genomic medicine workforce: a revised framework for UK practice-position on behalf of the Association of Genetic Nurses and Counsellors and the Clinical Genetics Society.

B-cell depletion therapy in systemic lupus erythematosus: emerging strategies and challenges.

68Ga-FAPI PET/CT for assessing fibroblast activation and disease activity in primary Sjögren's disease: a prospective case-control study.

Rheumatoid arthritis flares and de novo inflammatory arthritis after immune checkpoint inhibitor therapy: a single-center exploratory study of clinical phenotypes.

Related Experiment Videos

Antinuclear factor in rapid and slow acetylator patients treated with isoniazid

Related Concept Videos

Related Articles